These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 21998452
1. Inhibition of autoimmune diabetes by TLR2 tolerance. Kim DH, Lee JC, Kim S, Oh SH, Lee MK, Kim KW, Lee MS. J Immunol; 2011 Nov 15; 187(10):5211-20. PubMed ID: 21998452 [Abstract] [Full Text] [Related]
2. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ. Diabetes; 2007 Aug 15; 56(8):2116-23. PubMed ID: 17496235 [Abstract] [Full Text] [Related]
3. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. Zhang Y, Lee AS, Shameli A, Geng X, Finegood D, Santamaria P, Dutz JP. J Immunol; 2010 May 15; 184(10):5645-53. PubMed ID: 20393135 [Abstract] [Full Text] [Related]
4. Role of TLR2 in the pathogenesis of autoimmune diabetes and its therapeutic implication. Lee MS, Kim DH, Lee JC, Kim S, Kim HS. Diabetes Metab Res Rev; 2011 Nov 15; 27(8):797-801. PubMed ID: 22069262 [Abstract] [Full Text] [Related]
5. Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition. Kim DH, Lee JC, Lee MK, Kim KW, Lee MS. Diabetologia; 2012 Dec 15; 55(12):3308-17. PubMed ID: 23011352 [Abstract] [Full Text] [Related]
6. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Kim HS, Han MS, Chung KW, Kim S, Kim E, Kim MJ, Jang E, Lee HA, Youn J, Akira S, Lee MS. Immunity; 2007 Aug 15; 27(2):321-33. PubMed ID: 17707128 [Abstract] [Full Text] [Related]
8. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Kim S, Kim HS, Chung KW, Oh SH, Yun JW, Im SH, Lee MK, Kim KW, Lee MS. Diabetes; 2007 Oct 15; 56(10):2561-8. PubMed ID: 17620422 [Abstract] [Full Text] [Related]
9. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A. J Immunol; 1999 Jul 15; 163(2):743-50. PubMed ID: 10395666 [Abstract] [Full Text] [Related]
10. IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice. Tai N, Yasuda H, Xiang Y, Zhang L, Rodriguez-Pinto D, Yokono K, Sherwin R, Wong FS, Nagata M, Wen L. Clin Immunol; 2011 Jun 15; 139(3):336-49. PubMed ID: 21458378 [Abstract] [Full Text] [Related]
11. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS, Balasa B, Davies JD, Sarvetnick N. J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077 [Abstract] [Full Text] [Related]
12. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes. Millet I, Wong FS, Gurr W, Wen L, Zawalich W, Green EA, Flavell RA, Sherwin RS. J Autoimmun; 2006 Feb 01; 26(1):7-15. PubMed ID: 16338119 [Abstract] [Full Text] [Related]
13. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. Kägi D, Ho A, Odermatt B, Zakarian A, Ohashi PS, Mak TW. J Immunol; 1999 Apr 15; 162(8):4598-605. PubMed ID: 10201999 [Abstract] [Full Text] [Related]
14. Pam3CSK(4) enhanced beta cell loss and diabetogenesis: the roles of IFN-gamma and IL-17. Al Shamsi M, Shahin A, Iwakura Y, Lukic ML, Mensah-Brown EP. Clin Immunol; 2013 Oct 15; 149(1):86-96. PubMed ID: 23899994 [Abstract] [Full Text] [Related]
15. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M. J Immunol; 1996 Oct 15; 157(8):3737-43. PubMed ID: 8871677 [Abstract] [Full Text] [Related]
19. Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor. Suri A, Shimizu J, Katz JD, Sakaguchi S, Unanue ER, Kanagawa O. Eur J Immunol; 2004 Feb 15; 34(2):447-54. PubMed ID: 14768049 [Abstract] [Full Text] [Related]